BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

553 hedge funds and large institutions have $15.5B invested in BioMarin Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 196 increasing their positions, 191 reducing their positions, and 59 closing their positions.

Holders
553
Holders Change
+5
Holders Change %
+0.91%
% of All Funds
8.72%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
67
Increased
196
Reduced
191
Closed
59
Calls
$148M
Puts
$158M
Net Calls
-$9.91M
Net Calls Change
-$124M

Top Buyers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$360M
2
Barclays
2
Barclays
United Kingdom
$231M
3
American Century Companies
3
American Century Companies
Missouri
$45.5M
4
EAM
4
Eagle Asset Management
Florida
$38M
5
SI
5
Scout Investments
Missouri
$81.6M

Top Sellers

1
Invesco
1
Invesco
Georgia
$85.3M
2
Amundi
2
Amundi
France
$37M
3
BlackRock
3
BlackRock
New York
$1.21B
4
Jennison Associates
4
Jennison Associates
New York
$15.4M
5
Capital Research Global Investors
5
Capital Research Global Investors
California
$586M
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$1.59B 18,383,619 +140,190 +0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.54B 17,741,706 +208,460 +1%
Dodge & Cox
3
Dodge & Cox
California
$1.24B 14,290,303 -39,010 -0.3%
BlackRock
4
BlackRock
New York
$1.21B 14,015,465 -623,111 -4%
Capital Research Global Investors
5
Capital Research Global Investors
California
$586M 6,756,032 -452,927 -6%
State Street
6
State Street
Massachusetts
$516M 5,953,684 -112,634 -2%
Ameriprise
7
Ameriprise
Minnesota
$424M 4,888,513 -49,833 -1%
Viking Global Investors
8
Viking Global Investors
Connecticut
$360M 4,156,785 +1,988,168 +92%
ACA
9
Avoro Capital Advisors
New York
$347M 4,000,000 +55,000 +1%
BBA
10
Baker Bros. Advisors
New York
$330M 3,810,248 – –
Bank of America
11
Bank of America
North Carolina
$317M 3,660,140 +144,310 +4%
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$294M 3,389,646 -47,638 -1%
Norges Bank
13
Norges Bank
Norway
$263M 3,036,499 +152,016 +5%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$235M 2,711,025 +48,902 +2%
Barclays
15
Barclays
United Kingdom
$231M 2,661,271 +1,056,445 +66%
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$226M 2,611,317 +57,391 +2%
Parnassus Investments
17
Parnassus Investments
California
$203M 2,338,529 – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$190M 2,187,475 +107,826 +5%
PAMS
19
Pictet Asset Management (Switzerland)
Switzerland
$179M 2,063,810 +9,288 +0.5%
Deutsche Bank
20
Deutsche Bank
Germany
$173M 1,995,006 -101,769 -5%
PAI
21
Palo Alto Investors
California
$159M 1,831,035 – –
O
22
OrbiMed
New York
$140M 1,615,210 – –
Goldman Sachs
23
Goldman Sachs
New York
$124M 1,434,897 +306,018 +27%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$112M 1,291,678 -2,369 -0.2%
Charles Schwab
25
Charles Schwab
California
$110M 1,271,205 +12,173 +1%
1
2 3 4 5